Today’s AI Top Pick: HURN

7/2/2026 · Low Float Bullish Consensus Deep Rotation screen · a free sample of K3vl4r’s AI-curated picks.

AI-ranked from a screened shortlist, with entry strategy, targets, and risks.

Today's pick · Low Float Bullish Consensus Deep RotationHURNBUY NOW8.7 / 107/2/2026

HURN is the cleanest multi-timeframe setup in the pool combined with genuinely high-quality fundamentals. Every forecast horizon points up: 1h fc_mid +23.04% / fc_long +27.79%, 4h fc_mid +58.66% / fc_long +80.36%, 1d fc_mid +43.4% / fc_long +27.86%, and even the beaten-down 1wk shows fc_mid +19.65% / fc_long +27.77%. The only softness is the 1wk short-term (-6.71%), which is consistent with a base still forming rather than a broken trend. bullish_prob = 1.0 and near_term_bullish = 1.0 — the model has full conviction across horizons. Critically, you are NOT chasing here. Position-in-range is 71.56 / 40.05 / 30.52 / 10.72 across 1h→1wk, with a 1wk drawdown of -33.45% and daily drawdown -12.81%. RSI sits at 43.39. This is a deep-value pullback in a name that has already been marked down -44.26% YTD, not a euphoric breakout. The screen thesis — Float ≤ 20M with Forecast Consensus ≥ 1 — is exactly what deep-rotation rebounds live off of. Fundamentals confirm the tape. PE 16.46, fwdPE 9.43, PEG 1.02, ROE 23.27%, operMargin 11.77%, salesYoY +11.79%, epsNextY +15.64%. Analyst recom is 1.00 (unanimous strong buy) with targetUpsidePct of +91.2%. Instituional ownership 107.59% signals concentrated, committed sponsorship. Fundamental score is 7/8 — the highest quality name after MORN, and MORN is stretched at the 100th percentile of its 1h range with near_term_bullish only 0.4. News is benign: a director sold a tiny 1,800-share lot (immaterial), plus a Zacks 'strength seen' note and a StockStory 'explosive upside' piece. No dilution, no guidance cut, no regulatory overhang — unlike SNAL (1-for-5 reverse split), AMIX (1-for-21 reverse split), CRVO (dilutive $10M offering), TRAW (downgrade + $1 PT), or BIAF ($3.2M offering at $0.80). DCBO and MORN score similarly on fundamentals but are pinned at the top of the 1h range (100/100 and 100/71), so you'd be paying up. HURN is the rare 'quality-at-a-discount, forecast-confirmed, no landmine' setup — that's why today is the entry.

Entry zone

$94.50–$97.00 (current $96.38; scale in, add on any dip toward the 4h dd zone)

Stop loss

$84.90 (below the 1wk drawdown low ~-12% from entry; setup is invalidated if it takes out the base)

First target

$110–$113 (aligns with 1d fc_short +23.75% and reclaim of the 21-bar high)

Longer target

$135–$145 (1d fc_mid +43.4% / 4h fc_long +80.36% area; also lines up with 91.2% analyst target upside)

Risks

Weekly momentum still weak — 1wk recent_21bar_pct -23.12% and 1wk fc_short -6.71%; a lower low would break the thesis before mid-term forecasts play out
Debt/Equity 2.23 — leverage magnifies any consulting-services revenue miss; operMargin only 11.77% leaves limited cushion
Insider selling headline (director sold 1,800 shares 6/30) — minor size but worth monitoring for a pattern
Consulting sector cyclicality: -44.26% YTD reflects real demand concerns; a macro slowdown could extend the drawdown
Float ≤ 20M cuts both ways — moves are amplified in both directions, stop should be respected mechanically

Honorable mentions

DCBOBest fundamentals in pool (ROE 132.85%, PEG 0.46, fwdPE 9.45, recom 1.33) with 1wk fc_mid +105.4% and near_term_bullish 0.8 — but sitting at 100th percentile of the 1h/4h/1d ranges, so it's a BUY_PULLBACK, not a BUY_NOW. Wait for a dip to $17.

GPIDeepest oversold setup (RSI 31.41, pos_in_range 0/0.17/0/0), cheap (PE 10.96, fwdPE 6.04, PEG 0.69) with unanimous forecasts up on 1h/4h/1d. Held back to #3 because Russell Growth Index removal (6/30) creates forced selling and 1wk fc_short/mid turned mildly negative.

Full ranking (30)

#	Symbol	Verdict	Score	Read
1	HURN	BUY NOW	8.7	All 4 timeframes bullish, mid-range position, ROE 23%, unanimous strong-buy, +91% target upside, no news landmines.
2	DCBO	BUY PULLBACK	8.0	Elite fundamentals (ROE 132.85%, PEG 0.46) but pinned at 100th percentile of 1h/4h/1d — wait for a dip.
3	GPI	BUY NOW	7.8	Deep-value auto retailer, RSI 31, PE 10.96, pos_in_range ~0 — Russell removal creates the dip you buy, but 1wk mid fc slightly negative.
4	MORN	BUY PULLBACK	7.5	Top fundamentals (ROE 30.66%, opMargin 22.52%) but 1h at 100th percentile and near_term_bullish only 0.4 — don't chase.
5	TASK	BUY NOW	7.0	PE 4.43, fwdPE 3.27, targetUpside 75%, 4h fc_long +201.79%; recom 2.86 is a check but setup is compelling.
6	IDN	WAIT	6.3	Russell inclusion positive, but fwdPE 24.5 and 1wk deeply broken (dd -50.94%, pos 1.70) — needs base.
7	STEM	BUY PULLBACK	6.0	Storage tailwind, 1wk forecasts astronomical (likely outliers), recom 3.0 is neutral, at 1h range top.
8	ELTX	BUY PULLBACK	5.9	100% CR data + Russell inclusion + $12 PT is strong, but 1d dd -73.4% shows recent trauma; wait for confirmation.
9	SHOE	BUY PULLBACK	5.6	Small-cap bargain thesis with PE 11.16, pos_in_range 10/0 — decent but only 2 timeframes and shortFloat 17.59%.
10	MRLN	WAIT	5.4	De-risking + C-130J program progress, but shortFloat 55.59% and PS 545 make this a squeeze/story name, not a fundamentals buy.
11	LBRDA	WAIT	5.2	fwdPE 5.39 and reorganization catalyst, but salesYoY -74.83% and profitMargin -1050% — cheap for a reason.
12	GLMD	WAIT	5.0	Micro-cap healthcare with restructured acquisition; forecasts wild (1wk +1602%) but zero revenue visibility.
13	ANNA	BUY PULLBACK	4.9	PE 19.63, opMargin 30.31%, salesYoY +1533% — real growth, but 1wk fc_short -4.59% and pos 4.71 signals base.
14	XTLB	WAIT	4.7	Micro-cap ADR, targetUpside 141%, near_term_bullish 0.8 — but no revenue, forecasts are noisy.
15	PRSO	WAIT	4.5	Recom 1.0 and 1wk fc_short +585% but salesYoY -40.57% and profitMargin -73% — story stock.
16	AMIX	AVOID	4.2	1-for-21 reverse split (6/18) is a red flag; ROE -238% — pass despite bullish forecast.
17	VWAV	WAIT	4.1	Meteor Aerospace acquisition doubled shares — momentum is real but bullish_prob is null and data incomplete.
18	GRCE	WAIT	4.0	Q4 EPS beat but shortFloat 16.08% and 1wk dd -56.34% — needs a durable base.
19	NXL	AVOID	3.9	PS 27.92, opMargin -3084%, profitMargin -3022% — clinical trial optics only.
20	CRVO	AVOID	3.7	Just raised $10M at $4/share — dilution undercuts the patent-win rally; 1h fc_short -9.4%.
21	MNTS	AVOID	3.5	$75M ATM equity program (6/18) — perpetual dilution machine, 1d dd -60.06%, near_term_bullish 0.
22	SNAL	AVOID	3.4	1-for-5 reverse split effective 7/2 — screen thesis broken by structural action.
23	SAGT	WAIT	3.3	PE 8.56 and salesYoY +57% look ok but recent 82% after-hours pop + no bullish_prob makes it speculative.
24	CRE	WAIT	3.2	PE 6.55 and salesYoY +26% but instOwn 0.01% and no bullish_prob — illiquid micro-cap.
25	INTZ	WAIT	3.0	M&A into VigilAigent is interesting but profitMargin -169% and bullish_prob null.
26	AIFA	AVOID	2.9	CEO resignation (6/17) plus 57% acquisition SPA — governance chaos, only 2 timeframes.
27	TRAW	AVOID	2.7	HC Wainwright downgrade to Neutral with $1 PT (6/18) undercuts the forecast; 1d dd -44.59%.
28	TTEC	AVOID	2.6	DebtEq 11.65, shortFloat 32.61%, 1wk fc_short -85% — too many red flags.
29	BCG	WAIT	2.5	PE 12.99 with growth ambitions but instOwn 1.76% and no analyst target — thin coverage.
30	BIAF	AVOID	2.2	$3.2M offering at $0.80 (6/17) — dilution during a downtrend, RSI 28.24.

Get AI top picks & forecasts on any stock

K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.

Create your free account →

Already a member? Sign in · Join our Discord